GPGI, Inc. (GPGI) Form 8-K — Nov 5, 2026
GPGI reported 3Q26 results in line with expectations, with Pro Forma Adjusted Net Sales of $509.6 million (+4.5% y/y), Pro Forma Adjusted EBITDA of $146.3 million (+6.6% y/y) at a 28.7% margin, and GAAP net income of $76.0 million. CompoSecure delivered record sales of $140.7 million (+16.4% y/y) while Husky returned to modest revenue growth (+0.5% y/y). The company lowered FY26 Adjusted EBITDA guidance by roughly 8% (about $45 million at the midpoint) and Adjusted Free Cash Flow guidance by roughly 8% (about $25 million), attributing the shortfall to cost execution misses at Husky rather than demand, while reaffirming its full-year sales forecast.
Key figures
- Eps
- 0.26
- Revenue
- 509600000
- Guidance
- FY26: Pro Forma Adjusted Net Sales $2,034-$2,064M (+1% y/y at midpoint); Pro Forma Adjusted EBITDA $520-$550M (down 2% y/y at midpoint, ~8%/$45M cut); Pro Forma Adjusted Free Cash Flow $250-$300M (~$25M cut). 4Q26: Net Sales $630-$660M, EBITDA $178-$208M.
- Net Income
- 76000000
- Total Debt
- 2097000000
- Revenue Yoy
- 4.5%
- Cash Position
- 175800000
- Net debt
- 1921000000
- Husky sales yoy
- 0.5%
- Net debt leverage
- 3.7x
- Dividend per share
- 0.0025
- Dividend record date
- November 18, 2026
- Husky net sales 3q26
- 368900000
- Dividend payable date
- December 1, 2026
- Composesecure sales yoy
- 16.4%
- Composesecure net sales 3q26
- 140700000
- Pro forma ebitda margin 3q26
- 28.7%
- Pro forma adjusted ebitda 3q26
- 146300000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.